Doylestown Hospital Cancer Center is a clinical research site located in Doylestown, Pennsylvania, United States 18901.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Doylestown Hospital Cancer Center has participated in 8 clinical trials.
Therapeutic areas: Colorectal Cancer, Precancerous Condition, Leukemia.
Sponsors: NSABP Foundation Inc, Eastern Cooperative Oncology Group, Alliance for Clinical Trials in Oncology.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Doylestown Hospital Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Doylestown Hospital Cancer Center has 8 clinical trials on record. Their work covers Colorectal Cancer, Precancerous Condition, Leukemia.
Yes — Doylestown Hospital Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.